Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 19 March 2024 “ 6PM CET Disclosure notification from Mawer Investment Management Ltd. On 18 March 2024, Fagron received a...
Fagron publishes annual report 2023
Regulated information inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 15 February 2024 7AM CET Fagron delivers strong performance with 12% topline growth and 14% increase in...
Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 8 January 2024 8AM CET Disclosure notification from AOC Pharma S.Ã r.l. passing 10% threshold On 27 December 2023,...
Enforcement Report - Week of December 27, 2023
Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 11 December 2023 6PM CET Disclosure of notification received from BNP Paribas Asset Management SA Fagron received a...
Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 12 October 2023 “ 7:00 AM CET Continued strong third quarter performance with 11% topline growth to ‚¬191...
Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 19 September 2023 6PM CET Fagron completes share buy-back program Fagron has successfully completed its share buy-back program...
Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 15 September 2023 “ 6PM CET Progress share buy-back program Fagron In the period from 11 September 2023 through 15 September...
Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 8 September 2023 “ 6PM CET Progress share buy-back program Fagron In the period from 4 September 2023 through 8 September 2023,...